Pharmasyntez Group Of Companies

Pharmasyntez Group Of Companies company information, Employees & Contact Information

The Pharmasyntez Group is a Russian pharmaceutical company, which is engaged in development and production of up-to-date, high quality, and affordable medicines. It has been at the pharmaceutical market since 1997. The company activities are focused on development and production of pharmaceuticals meant for the treatment of socially significant diseases, such as tuberculosis, HIV/AIDS, oncology, diabetes mellitus, hepatitis, and blood diseases.

Company Details

Employees
184
Founded
-
Address
Улица Розы Люксембург 184, Иркутск,иркутская Область 664048,russian Federation
Phone
+7 (3952) 55-03-55
Email
in****@****tez.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Иркутск, Иркутская область
Looking for a particular Pharmasyntez Group Of Companies employee's phone or email?

Pharmasyntez Group Of Companies Questions

News

Pharmasyntez plans massive expansion of portfolio of innovative drugs - The Pharma Letter

Pharmasyntez plans massive expansion of portfolio of innovative drugs The Pharma Letter

Pharmasyntez has announced the release of three innovative drugs - Новости GxP

Pharmasyntez has announced the release of three innovative drugs Новости GxP

Pharmasyntez has developed a new drug against blood cancer - Новости GxP

Pharmasyntez has developed a new drug against blood cancer Новости GxP

Some Russian drugmakers focus on export-oriented Sputnik Light shot - Reuters

Some Russian drugmakers focus on export-oriented Sputnik Light shot Reuters

Partnerships formed and extended between Isu Abxis/Pharmasyntez and Alvotech/Fuji Pharma - Generics and Biosimilars Initiative

Partnerships formed and extended between Isu Abxis/Pharmasyntez and Alvotech/Fuji Pharma Generics and Biosimilars Initiative

Russian Supreme Court Backs Government In Patent Dispute Over Remdesivir COVID Treatment - Radio Free Europe/Radio Liberty

Russian Supreme Court Backs Government In Patent Dispute Over Remdesivir COVID Treatment Radio Free Europe/Radio Liberty

Daewoong inks $60 million deal to export diabetes drug to Russia, CIS countries - koreabiomed.com

Daewoong inks $60 million deal to export diabetes drug to Russia, CIS countries koreabiomed.com

Daewoong Pharmaceutical to launch new diabetes treatment in CIS countries - The Korea Herald

Daewoong Pharmaceutical to launch new diabetes treatment in CIS countries The Korea Herald

Russia's Pharmasyntez eyes launch of large-scale production of dialysis drugs - The Pharma Letter

Russia's Pharmasyntez eyes launch of large-scale production of dialysis drugs The Pharma Letter

Daewoong Pharmaceutical Exports ‘Enavogliflozin’ to Russia, CIS Countries - Businesskorea

Daewoong Pharmaceutical Exports ‘Enavogliflozin’ to Russia, CIS Countries Businesskorea

Russia extends production of COVID-19 drug remdesivir without patent for a year - Reuters

Russia extends production of COVID-19 drug remdesivir without patent for a year Reuters

Russia Allows Domestic Pharmaceutical To Continue Producing U.S. Company's COVID-19 Drug - Radio Free Europe/Radio Liberty

Russia Allows Domestic Pharmaceutical To Continue Producing U.S. Company's COVID-19 Drug Radio Free Europe/Radio Liberty

Meet Jaipur-born businessman, a billionaire, owns pharma company in Russia, played key role in making Sputnik - India.Com

Meet Jaipur-born businessman, a billionaire, owns pharma company in Russia, played key role in making Sputnik India.Com

Pharmasyntez has made it’s first delivery of anticancer drugs to the Dominican Republic - Новости GxP

Pharmasyntez has made it’s first delivery of anticancer drugs to the Dominican Republic Новости GxP

Pharmasyntez plans to boost drug exports 5-10 times in next 2 years - Новости GxP

Pharmasyntez plans to boost drug exports 5-10 times in next 2 years Новости GxP

Health Ministry approved Pharmasyntez’s schizophrenia treatment drug - Новости GxP

Health Ministry approved Pharmasyntez’s schizophrenia treatment drug Новости GxP

Pharmasyntez has commenced the production of gensulins in Russia - Новости GxP

Pharmasyntez has commenced the production of gensulins in Russia Новости GxP

Top Pharmasyntez Group Of Companies Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant